CJC-1295
Research growth-hormone–release peptide — not FDA-approved.
What it's for
CJC-1295 is a lab-made peptide related to growth-hormone–releasing hormone (GHRH (growth-hormone–releasing hormone, a brain signal that asks the pituitary to release growth hormone)) research, sometimes discussed with or without a drug-extending modification (DAC).
What it does for the body
It has been studied for raising growth hormone and IGF-1 signals. It is not FDA-approved as an anti-aging or performance medicine. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
It mimics GHRH (growth-hormone–releasing hormone, a brain signal that asks the pituitary to release growth hormone)-style signals that tell the pituitary to release growth hormone. Imagine turning up the growth hormone thermostat rather than injecting growth hormone itself. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Belongs to a class of GHRH (growth-hormone–releasing hormone, a brain signal that asks the pituitary to release growth hormone) analogs explored in endocrine research. Educational framing only — not a use guide.
Studied for (literature interest)
- Growth-hormone releasing hormone (GHRH (growth-hormone–releasing hormone, a brain signal that asks the pituitary to release growth hormone)) pathway research
- Interest in body-composition and recovery literature — not large definitive outcome trials for general use
Cautions (educational)
- Not FDA-approved for general human use as a wellness peptide.
- This encyclopedia does not provide dosing or sourcing.
Citations / starters
- PubMed search: CJC-1295 — NCBI PubMed
- ClinicalTrials.gov search: CJC-1295 — U.S. clinical trials registry
- FDA search: CJC-1295 — FDA.gov
- Drugs@FDA search: CJC-1295 — FDA drug database (if approved)
- OpenAlex works: CJC-1295 — Open scholarly index
Reference
Ref $69 ref only